Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avecho Biotechnology Ltd V.AVE


Primary Symbol: AVEFF

Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from vitamin E using patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol and Veterinary Applications. The Company is also developing TPM to enhance feed efficiency and the health of livestock. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.


OTCPK:AVEFF - Post by User

Comment by rusty777on Oct 31, 2019 2:16pm
72 Views
Post# 30293250

RE:Aveda Earn Out

RE:Aveda Earn OutThanks for the info Johnny

This does not bode well for the Aveda shareholders.  They have been putting this off for some time now and it looks like for all intents and purposes they are putting it off indefinately.  It would not surprise me if at the end of all this they tell us there was no earn out (all they have to do is simply spend whatever profit Aveda has generated to bring the earnout to "0")  

this is particularily interesting given that I was speaking with one of the drivers at a truck stop on the Trans Canada who is now part of the "Dasake Family".  He just loves the company. Apparently, his income has more than doubled since joining Dasake and he has been told that the focus of the company is presently to "reinvest in personell be they drivers admin or management as well as equipment and infrastructure"  and that they are not one of those companies that "worship the shareholder at the expense of the workers".  I have no idea as to the veracity of these statements and have really no way to confirm or deny what I have been told.

So if the focus is on spending, spending, spending.  (I said IF)..there will be no change in share price or any earnouts in the near future that I can see.  Certainly, the share price at present seems to support the lack of funds available to increase shareholder value.  Third quarter earnings will be interesting but I am not overly optimistic.  In spite of record low interest rates and gas prices I would not be surprised if there will be a number of "unanticipated costs" which drained the various company accoounts.

Any thoughts?

GLTA

Rusty
<< Previous
Bullboard Posts
Next >>